Skip to content
Open access

A Pilot Head-to-Head Comparison of Two Bisulfite Conversion Kits for NGS-Based DNA Methylation Analysis of Liquid Biopsy Samples from Colorectal Cancer

Sep 2026 · Cancers · Vol 18, pp. 3148 · 0 citations · 31 references
Medicine

TL;DR

The EZ DNA Methylation Kit is compared and it is suggested that this kit provides a more reliable approach for cfDNA methylation profiling and may improve the accuracy of liquid biopsy-based cancer detection.

Abstract

Simple Summary DNA methylation is a promising biomarker for the early detection and diagnosis of cancer using circulating cell-free DNA (cfDNA). Reliable methylation analysis depends on efficient bisulfite conversion, a key step in preparing DNA for sequencing. In this pilot study, we compared two commonly used bisulfite conversion kits: the EpiTect Bisulfite Kit and the EZ DNA Methylation Kit. The EZ DNA Methylation Kit showed superior performance, producing higher cfDNA yields, greater bisulfite conversion efficiency, improved mapping rates, and lower duplication rates. These findings suggest that this kit provides a more reliable approach for cfDNA methylation profiling and may improve the accuracy of liquid biopsy-based cancer detection.

Read PDF

Similar papers

Oct 2026

B-070 Automated bisulfite conversion for methylation analysis in cervical cancer screening: validation of the Methica CC Kit supported with PurePrep 96 workflow

DNA methylation analysis has been shown to be a promising biomarker for triage of hrHPV-positive women in cervical cancer screening. The Methica CC Kit detects promoter hypermethylation of 3 DNA methylation markers (C13ORF18, JAM3 and ANKRD18CP) with high sensitivity for high-grade cervical intraepithelial neopla...

Nutte Belzen · 0 citations
Open access Oct 2026

A Dual-Marker DNA Methylation Assay Enables High-Sensitivity Detection of Malignant Effusions Across Cancer Types

Simple Summary Distinguishing malignant from benign pleural and peritoneal effusions is essential for cancer diagnosis and treatment, but routine cytology often fails to detect malignant cells. We evaluated a DNA methylation test based on two cancer-related genes, SHOX2 and RASSF1A, in 696 patients with pleural or peri...

Ting Wang, Ting Liang, Matthew Kafarski et al. · 0 citations
Open access Sep 2026

Comparison of Four Bisulfite Conversion Kits and Their Effects on DNA Methylation Detection and Age Prediction

Background/Objectives: This study aimed to compare the performance of four commercial bisulfite conversion kits—the Premium Bisulfite Kit, the SuperMethyl™ Fast Bisulfite Conversion Kit, the SuperMethyl™ Max Bisulfite Conversion Kit, and the EZ DNA Methylation-Gold™ Kit (hereafter: Premium, Fast, Max, and Gold)—to eval...

Monica Giuffrida, C. Børsting, V. Pereira · 0 citations
Open access Sep 2026

Urine DNA methylation as a potential diagnostic and surveillance tool in non-muscle invasive bladder cancer in Thailand: A pilot study

Non-muscle invasive bladder cancer (NMIBC) exhibits high recurrence, necessitating frequent invasive surveillance. Urine DNA methylation profiling represents a promising non-invasive biomarker approach for early detection and monitoring. This pilot study aimed to investigate urine DNA methylation patterns in NMIBC amon...

T. Watcharawitayakul, J. Ophanurak, D. Sowanthip et al. · 0 citations
Open access Oct 2026

Genome-Wide DNA methylation profiling of tissue-plasma pairs identifies Novel cfDNA biomarkers for the diagnosis of gastric cancer

Screening for gastric cancer (GC) is critical for improving patient survival, yet current clinical methods suffer from invasiveness and limited sensitivity. The aim of this study is to develop a machine learning model for the non-invasive diagnosis of GC using the whole-genome methylation profile of circulating free DN...

H. Ou, J. Miao, Fu-Sheng Ling et al. · 0 citations
Oct 2026

B-063 Digital Microfluidic Platform for Single-Molecule DNA Methylation Profiling within Complex Specimens

Aberrant DNA methylation is an early and pervasive hallmark of tumorigenesis and represents a promising biomarker class for noninvasive cancer detection. However, detection of rare, heterogeneously methylated tumor-derived DNA molecules in complex clinical specimens remains technically challenging. Conventional m...

C. O'Hersey, J. Wang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.